ArticleVaccines2023

Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations.

Hak-Jun Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.